- Neuro-All - University of Manitoba Mailing Lists

videolink of recorded talk - Dr. Ben Albensi
by Kelly Jorundson 29 Apr '11

29 Apr '11

Dear all, Here is the link for Dr. Albensi's talk held this morning at 9am. (Please note that the first 15 min has been missed) http://sbrc.tv/1/watch/175.aspx Manitoba Neuroscience Network Seminar: Dr. Ben Albensi <http://www.sbrc.ca/content/blogcategory/102/149/> Date: Friday, April 29, 2011 Time: 9:00am Location: Samuel Cohen Auditorium, SBRC Campus ** **Video-linked to Bannatyne Campus (Theatre B) TOPIC: Neurostimulation in Epilepsy and Beyond Dr. Ben Albensi Everett Endowment Fund Chair Associate Professor of Pharmacology & Therapeutics Adjunct Professor of Electrical & Computer Engineering Principal Investigator - Division of Neurodegenerative Disorders, SDt. Boniface Research Centre Summary of Research: Dr. Albensi's lab is focused on understanding hippocampal dysfunction. Situated deep in the temporal lobe of the human brain, lays the hippocampal formation, a network of circuits unlike any other structure in the nervous system. The hippocampus is the site of many disease processes, but there are two diseases that stand out; those being Alzheimer's disease and epilepsy. To this end, he has investigated the biological basis of memory impairment and alterations in neuronal excitability (eg., seizures) in the hippocampus caused by calcium overload and alterations in NF-kB signaling. He has developed several animal models to explore both novel mechanisms and novel therapies for treatment of those diseases. His methods include, electrophysiology, calcium imaging, behavioral tests, MRI, and standard cell and molecular assays. His seminar will focus on novel therapies, such as neurostimulation, for treating epilepsy and other disorders. ***Don't forget to register for the Manitoba Neuroscience Network's 2nd Annual Meeting <http://www.sbrc.ca/mnn2011> to be held on Monday, June 13, 2011. To learn more about this exciting meeting, visit the conference website at www.sbrc.ca/mnn2011 Kelly Jorundson Winnipeg Chapter Society for Neuroscience R4046 - 351 Taché Avenue Winnipeg, MB R2H 2A6 CANADA Tel: 204.235.3939 7Fax: 204.237.4092 Email: kjorund(a)sbrc.ca <mailto:kjorund@sbrc.ca>

1 0

Link problems with MNN Seminar this morning
by Winnipeg Chapter Society for Neuroscience 29 Apr '11

29 Apr '11

Dear all, For those affected by the lost transmission of the video-linked MNN talk (B Albensi) to Theatre B, Bannatyne Caqmpus, I will be sending around another email around 10:30am with a link where you will be able to watch see a recorded version. We apologize for this inconvenience, apparently the Bannatyne campus was having problems with their videoconference equipment. /sent on behalf of Chris Anderson Kelly Jorundson Winnipeg Chapter Society for Neuroscience R4046 - 351 Taché Avenue Winnipeg, MB R2H 2A6 CANADA Tel: 204.235.3939 7Fax: 204.237.4092 Email: kjorund(a)sbrc.ca <mailto:kjorund@sbrc.ca>

1 0

MNN Seminar - Dr. Ben Albensi
by Winnipeg Chapter Society for Neuroscience 27 Apr '11

27 Apr '11

Presented in conjunction with the Winnipeg Chapter Society for Neuroscience <http://www.sfn-manitoba.ca/> & University of Manitoba Clinical Neuroscience Rounds.. Everyone is invited to attend: Manitoba Neuroscience Network Seminar: Dr. Ben Albensi <http://www.sbrc.ca/content/blogcategory/102/149/> Date: Friday, April 29, 2011 Time: 9:00am Location: Samuel Cohen Auditorium, SBRC Campus ** **Video-linked to Bannatyne Campus (Theatre B) TOPIC: Neurostimulation in Epilepsy and Beyond Dr. Ben Albensi Associate Professor of Pharmacology & Therapeutics Adjunct Professor of Electrical & Computer Engineering University of Manitoba & Everett Endowment Fund Chair Principal Investigator - Division of Neurodegenerative Disorders, St. Boniface Research Centre Summary of Research: Dr. Albensi's lab is focused on understanding hippocampal dysfunction. Situated deep in the temporal lobe of the human brain, lays the hippocampal formation, a network of circuits unlike any other structure in the nervous system. The hippocampus is the site of many disease processes, but there are two diseases that stand out; those being Alzheimer's disease and epilepsy. To this end, he has investigated the biological basis of memory impairment and alterations in neuronal excitability (eg., seizures) in the hippocampus caused by calcium overload and alterations in NF-kB signaling. He has developed several animal models to explore both novel mechanisms and novel therapies for treatment of those diseases. His methods include, electrophysiology, calcium imaging, behavioral tests, MRI, and standard cell and molecular assays. His seminar will focus on novel therapies, such as neurostimulation, for treating epilepsy and other disorders. ***Don't forget to register for the Manitoba Neuroscience Network's 2nd Annual Meeting <http://www.sbrc.ca/mnn2011> to be held on Monday, June 13, 2011. To learn more about this exciting meeting, visit the conference website at www.sbrc.ca/mnn2011 Kelly Jorundson Winnipeg Chapter Society for Neuroscience R4046 - 351 Taché Avenue Winnipeg, MB R2H 2A6 CANADA Tel: 204.235.3939 Fax: 204.237.4092 Email: wcsn(a)sbrc.ca Website: www.sfn-manitoba.ca

1 0

CAN Annual Meeting - travel funds available
by Winnipeg Chapter Society for Neuroscience 13 Apr '11

13 Apr '11

Dear Neuroscientists, The Canadian Association for Neuroscience (CAN) will be holding its 5th Annual Meeting May 29 to June 1 at the Québec City Convention Centre. While there are many options for our travel dollars, the CAN meeting has proven to be a useful conference of manageable size that brings together the best Canadian Neuroscientists. The meeting chair this year is Dr. Yves De Koninck and he has put together a very good program (www.canmeeting.ca). I encourage as many Manitobans as possible to attend this meeting. Several of us have been making an effort to showcase neuroscience in our province at this meeting since the first one but we need to do more. STUDENT TRAVEL FUNDS AVAILABLE: The CAN Secretary has informed me that significant travel funds are available for trainees (students and postdoctoral fellows) to travel to the 2011 CAN meeting provided local matching funds are available. Stakeholder academic departments and research institutes are committed to finding matching funds for trainees wishing to capitalize on this opportunity. If you are a student or postdoctoral fellow and would like to attend the CAN meeting, please advise myself (canderson(a)sbrc.ca) or Dr. Paul Fernyhough (pfernyhough(a)sbrc.ca) as soon as possible. Thank you. Chris Anderson Kelly Jorundson Winnipeg Chapter Society for Neuroscience R4046 - 351 Taché Avenue Winnipeg, MB R2H 2A6 CANADA Tel: 204.235.3939 7Fax: 204.237.4092 Email: kjorund(a)sbrc.ca <mailto:kjorund@sbrc.ca>

1 0

Canadian Society for Brain, Behavior and Cognitive Science Meeting, June 24-26, 2011
by Winnipeg Chapter Society for Neuroscience 08 Apr '11

08 Apr '11

The Annual Canadian Society for Brain, Behaviour and Cognitive Science Meeting will be held in Winnipeg at the Fort Garry Campus June 24-26, 2011. This meeting attracts visitors from all over Canada, as well as locations from around the world. The Canadian Society for Brain, Behaviour and Cognitive Science (CSBBCS) is a non-profit organization whose primary function is to advance Canadian research in experimental psychology and behavioural neuroscience. Conference details are available at: http://2011.csbbcs.org/ocs2/index.php/bbcs/2011/schedConf/overview Abstracts for talks and posters will be accepted until April 15th, 2011. The Hebb Winner, Dr. Ellen Bialystok, will be here speaking on her research on how bilingualism influences brain plasticity and aging. Her talk is entitled "Reshaping the Mind: The Benefits of Bilingualism". For more information contact: Tammy L. Ivanco, PhD. Associate Professor, Department of Psychology P415 Duff Roblin Building, 190 Dysart Road University of Manitoba Winnipeg, MB, R3T-2N2 204-474-7375

1 0

Department of Physiology Candidate Lectures, April 4 and 5, 2011
by Winnipeg Chapter Society for Neuroscience 31 Mar '11

31 Mar '11

The Department of Physiology Assistant Professor Candidate Lectures Katinka Stecina, Ph.D. Postdoc/Associate Professor Department of Neuroscience and Pharmacology Copenhagen University, Copenhagen, Denmark Research Lecture Monday, April 4, 2011 "Spinal neuronal circuits used for sensory-motor integration" Monday, April 4, 2011 at 1:00PM Physiology Library, Rm 431, BMSB 745 Bannatyne Avenue Teaching Lecture Tuesday, April 5, 2011 "Neuronal control of gait" Tuesday, April 5, 2011 at 10:00AM Biochemistry Conference Room, Room 341 Basic Medical Sciences Bldg, 745 Bannatyne Avenue All are welcome to attend. Posters attached. For more information contact: Dr. David McCrea Director: Spinal Cord Research Centre Phone: 789-3770 E-mail: dave(a)scrc.umanitoba.ca -- Spinal Cord Research Centre University of Manitoba Department of Physiology 409 - 745 Bannatyne Avenue Winnipeg, Manitoba R3E 0J9 204-789-3770

1 0

CAN welcomes the announcement of a $100M investment for Brain Research in budget 2011
by Winnipeg Chapter Society for Neuroscience 23 Mar '11

23 Mar '11

<http://app.expressemailmarketing.com/Images/Gallery/96721/images_/a203a53e-…> The Canadian Association for Neuroscience welcomes the announcement by the Government of Canada of an investment of $100 million in federal funding to match private donations directed to support Canadian brain research. Page 145 of the 2011 budget document states: "Advancing Knowledge and Treatment of Brain Disorders Disorders of the brain are one of the major health challenges of the 21st century. It is estimated that one in three Canadians will face a mental illness or a neurological disorder or injury at some point in their lives. Brain Canada is a national, non-profit foundation dedicated to supporting research into new diagnostics, treatments and ultimately cures for brain disorders. To support Brain Canada's efforts, Budget 2011 proposes to allocate up to $100 million to help establish the Canada Brain Research Fund, which will support the very best Canadian neuroscience, fostering collaborative research and accelerating the pace of discovery, in order to improve the health and quality of life of Canadians who suffer from brain disorders. Federal funding for this initiative will be matched by resources raised from Brain Canada's other partners. This funding will be matched by $100 million of private donations raised by Brain Canada over the next five years to support a co-ordinated, national research program, in partnership with Neurological Health Charities Canada and the Canadian Association of Neuroscience. The goal of Canada Brain Research Fund is to maximize the impact of current investments in neuroscience research in Canada and reinforce a position of global leadership in neuroscience research, a field with limitless economic potential. The plan is to implement a coordinated national strategy for brain research in Canada with funding from private individuals, the charitable sector, and the government. The Canada Brain Research Fund will aim to support transformative team research to bring the results of scientific advances directly to patients, a series of national technology platforms to advance brain research, and a training program to support the next generation of neuroscientists. The implementation of the program will be developed jointly by Government and the partners in the near future. Meeting the Challenge of Brain Disorders The brain is the most vital and complex organ in the human body. Disorders of the brain account for a broad spectrum of conditions encompassing psychiatric diseases and neurological disorders such as Alzheimer's and Parkinson's disease, amyotrophic lateral sclerosis, bipolar disorders, chronic pain, depression, epilepsy, multiple sclerosis, schizophrenia and brain and spinal cord injuries and stroke. The economic and human impact of brain disorders exceeds that of cancer and cardiovascular disease combined. These facts are not meant to diminish the gravity of other diseases. Rather they underscore the pervasiveness and nature of brain disorders. While some brain diseases respond to treatment, there are no cures at the present time. People with a brain disorder may live for a long time with certain conditions, or with other conditions, they will slowly degenerate and lose function before dying. The resulting economic burden in Canada is estimated at $60 billion, or about 38% of the total burden of disease. Canada has a unique opportunity to turn the challenge of brain disorders and their enormous economic burden on our economy and society into an opportunity for global leadership. The key to realizing this opportunity is to ensure that the community of researchers has funding of the scale and scope required to encourage research that has application across multiple diseases. The budget announcement shows that the Government of Canada recognizes the need for increased funding for brain research and they have responded with a plan for investment in Canadian neuroscience research. They recognize the excellence in the Canadian neuroscience community and the value of investing in research to reduce the burden of brain diseases on Canada. Yves De Koninck President Sam David President-Elect Brian MacVicar Past-president The Canadian Association for Neuroscience ________________________________ <http://app.expressemailmarketing.com/Images/Gallery/96721/images_/a203a53e-…> L'Association canadienne des neurosciences se réjouit de l'annonce faite par le gouvernement du Canada d'un investissement de $100 million en fonds fédéraux pour apparier des dons du privé pour soutenir la recherche sur le cerveau au Canada. À la page 164 du budget 2011 on peut lire : Mieux comprendre et traiter les troubles du cerveau Les troubles du cerveau constituent l'un des principaux défis du XXIe siècle dans le domaine de la santé. Selon les estimations, un Canadien sur trois sera atteint d'une maladie mentale ou d'un trouble ou d'une lésion neurologique à un moment donné de sa vie. Brain Canada est une fondation nationale à but non lucratif vouée au soutien de la recherche visant à mettre au point des méthodes diagnostiques, des traitements et, au bout du compte, des moyens de guérir les troubles du cerveau. Pour appuyer les efforts de Brain Canada, le budget de 2011 propose de consacrer jusqu'à 100 millions de dollars à l'appui de l'établissement d'un fonds canadien de recherche sur le cerveau, qui soutiendra les travaux de la plus haute qualité en science neurologique, favorisera la recherche concertée et accélérera le rythme des découvertes, afin d'améliorer la santé et la qualité de vie des Canadiens atteints de troubles du cerveau. Les autres partenaires de Brain Canada affecteront à cette initiative une somme équivalente à celle de la contribution fédérale. Ces fonds seront appariés par $100 million en dons privés qu'amassera Brain Canada au cours des cinq prochaines années afin de soutenir un programme national de recherche concerté en partenariat avec les Organismes caritatifs neurologiques du Canada et l'Association canadienne des neurosciences. L'objectif de cette initiative est de maximiser l'impact de l'investissement actuel en recherche en neurosciences au Canada et renforcer notre position de leader mondial dans ce domaine dont les potentiels économiques sont sans limite. Le plan est de mettre en place une stratégie nationale coordonnée pour la recherche sur le cerveau au Canada via une convergence de financement des secteurs privé, philanthropique, caritatif et gouvernemental. Le Fonds canadien de recherche sur le cerveau visera à soutenir des travaux de recherche d'équipe de nature transformative visant un transfert accéléré vers les patients, des plateformes technologies nationales pour soutenir la recherche sur le cerveau, et un programme de formation pour soutenir la prochaine génération de neuroscientifiques. Le programme sera développée prochainement en collaboration avec le gouvernement et les partenaires. Relever le défi des troubles du cerveau Le cerveau est l'organe le plus vital et le plus complexe du corps humain. Les troubles du cerveau sont responsables d'un grand nombre de maladies psychiatriques et neurologiques telles que les maladies d'Alzheimer et de Parkinson, la sclérose latérale amyotrophique, les troubles bipolaires, la douleur chronique, la dépression, l'épilepsie, la sclérose en plaque, la schizophrénie de même que les lésions du cerveau et de la moelle épinière dues à des traumatismes physiques et vasculaires cérébraux. L'impacte des troubles du cerveau en termes économiques et humains dépasse celui du cancer et des maladies cardiovasculaires combinées. Ces faits ne viennent en rien diminuer la gravité des ces autres maladies. Ils viennent souligner le caractère envahissant et le fardeau énorme des troubles du cerveau. Alors que certaines maladies du cerveau répondent bien à certains traitements, dans la plupart des cas, il n'existe aucun traitement curatif. Les personnes aux prises avec des désordres du cerveau peuvent le rester pendant de très longues périodes; leur condition se détériore souvent lentement pour finir avec une perte de fonction totale menant à la mort. Le fardeau économique qui en résulte est estimé à $60 milliards de dollars au Canada, soit environ 38% du fardeau total des maladies. Canada a une chance unique de transformer le défi des troubles du cerveau et de leur fardeau socio- économique en une opportunité de leadership au niveau mondial. La clé pour le réaliser est de s'assurer que la communauté des chercheurs soit soutenue financièrement à la hauteur nécessaire pour y arriver. L'annonce faite dans le budget fédéral montre que le gouvernement du Canada reconnait le besoin d'augmenter le financement de la recherche sur le cerveau et il a répondu avec un plan d'investissement pour le réaliser. Le gouvernement reconnait l'excellence de la recherche canadienne en neurosciences et la valeur d'un investissement en recherche pour réduire le fardeau des maladies du cerveau pour le Canada. Yves De Koninck Président Sam David Président-désigné Brian MacVicar Ancien président L'Association canadienne des neurosciences This email was sent by Yves De Koninck, 4994 de Maisonneuve Ouest, Suite 103, Montreal, Quebec H3Z 3B9, using Express Email Marketing. You were added to this list as kjorund(a)sbrc.ca on 3/2/2011. Express Email Marketing supports permission-based email marketing. You can change your preferences <http://app.expressemailmarketing.com/survey.aspx?id=96721&sid=158567815&cam…> or unsubscribe <http://app.expressemailmarketing.com/unsubscribe.aspx?id=96721&sid=15856781…> from this mailing list at any time. <http://app.expressemailmarketing.com/get.imgx?Opened=true&cid=732927&sid=15…>

1 0

Reminder: MNN Seminar - Dr. David Eisenstat
by Winnipeg Chapter Society for Neuroscience 23 Mar '11

23 Mar '11

The Winnipeg Chapter Society for Neuroscience is pleased to announce this upcoming Manitoba Neuroscience Network Seminar <http://www.sfn-manitoba.ca/news/?id+20101018wcsn.txt> ... Date: Friday, March 25, 2011 Time: 9:00 AM - 10:00 AM Location: Theatre B, Basic Medical Sciences Bldg., Bannatyne Campus Dr. David Eisenstat, MD, MA, FRCPC Director, Advanced Degrees in Medicine Program, Faculty of Medicine Director, Neuro-Oncology, CancerCare Manitoba Associate Professor, Departments of Pediatrics & Child Health, Human Anatomy & Cell Science, Ophthalmology, and Biochemistry & Medical Genetics Senior Investigator, Manitoba Institute of Cell Biology Scientist, Manitoba Institute of Child Health University of Manitoba Title: "Regulation of progenitor cell fate and survival in the developing retina". Dr. David Eisenstat is a Pediatric Hematologist/Oncologist and Neuro-Oncologist. He is also Director of the Advanced Degrees in Medicine Program in the Faculty of Medicine, University of Manitoba, the Director of Neuro-Oncology for CancerCare Manitoba, a Senior Investigator of the Manitoba Institute of Cell Biology and a Scientist, Manitoba Institute of Child Health. Dr. David Eisenstat's laboratory is interested in the interface between Cancer and Development as well as understanding the genetic regulation of brain and retina development. Dr. Eisenstat graduated from the University of Toronto's Faculty of Medicine in 1985. Following an internship emphasizing surgery and a subsequent residency year in Anatomic Pathology at the University of Toronto, David completed his Pediatrics residency at the Hospital for Sick Children, Toronto in 1990. After a Clinical Fellowship in Pediatric Hematology-Oncology, also at the Hospital for Sick Children, he was awarded a Fellowship from the Pediatric Scientist Development Program. David moved his family to San Francisco, where he joined the Brain Tumor Research Center at the University of California, San Francisco (UCSF). In 1993, David began a second postdoctoral fellowship funded by the Medical Research Council of Canada with Dr. John Rubenstein, also at UCSF, and was awarded a Master's degree in Neuroscience from UCSF in 1997. In 1998, David was a Clinical Fellow in Pediatric Neuro-Oncology at the University of Texas M.D. Anderson Cancer Center in Houston. After over 13 years of post-medical school training, he began his first faculty appointment at the University of Manitoba, Winnipeg, Canada, in 1999. Since 2005, he is an Associate Professor in the Department of Pediatrics & Child Health, and holds full cross-appointments as an Associate Professor in the Departments of Human Anatomy & Cell Science, Biochemistry & Medical Genetics and Ophthalmology, all at the University of Manitoba. For more information, contact the MNN Office at (T) 235.3939 or email: mnn(a)sbrc.ca Presented in co-operation with University of Manitoba Clinical Neuroscience Rounds An initiative of the Winnipeg Chapter Society for Neuroscience Kelly Jorundson Winnipeg Chapter Society for Neuroscience R4046 - 351 Taché Avenue Winnipeg, MB R2H 2A6 CANADA Tel: 204.235.3939 7Fax: 204.237.4092 Email: kjorund(a)sbrc.ca <mailto:kjorund@sbrc.ca>

1 0

5th CAN Meeting Travel Award Competition / 5ième congrès de l'ACN: Bourses de voyage
by Winnipeg Chapter Society for Neuroscience 22 Mar '11

22 Mar '11

<http://app.expressemailmarketing.com/Images/Gallery/96721/images_/a203a53e-…> TRAVEL AWARD COMPETITION TO ATTEND THE 2011 CANADIAN NEUROSCIENCE MEETING IN QUEBEC CITY: In partnership with several institutions across Canada, the Canadian Association for Neuroscience will provide travel support to a record number of trainees (graduate students and post-docs) this year to help them attend the 2011 Canadian Neuroscience Meeting in Quebec City (May 29-June 1). In partnership with local institutions in Toronto, Kingston, Ottawa and Montreal, CAN will subsidize chartered buses to allow trainees to attend the meeting at a nominal fee. We encourage trainees interested in taking advantage of these buses to contact their university representatives for more details on how to enroll in this program. For trainees from other Canadian cities, in partnership with local institutions, CAN will award between 25 and 40 travels awards in the amount of 500$ each to help defray travel and accommodation costs. Applications should be submitted by email to jsbains(a)ucalgary.ca <mailto:jsbains@ucalgary.ca> and should include: Identification of the candidate, degree sought, supervisor name, program enrolled in, University and/or Research Institute, title of presentation, list of authors and complete abstract. To be eligible for a travel award, the trainee must be the first and presenting author on the poster. Deadline for submission of applications: 12 April 2011. ________________________________ <http://app.expressemailmarketing.com/Images/Gallery/96721/images_/a203a53e-…> BOURSES DE VOYAGE POUR ASSISTER AU CONGRÈS DES NEUROSCIENCES CANADIENNES DE 2011 À QUÉBEC: En partenariat avec plusieurs institutions à travers le pays, l'Association canadienne des neurosciences offre un programme d'aide pour permettre à un nombre record de stagiaires de recherche (étudiants aux cycles supérieurs et post-docs) d'assister au congrès des Neurosciences canadiennes de 2011 à Québec (29 mai - 1 juin). En partenariat avec plusieurs institutions à Toronto, Kingston, Ottawa et Montréal, l'ACN subventionnera des autobus nolisés pour permettre aux stagiaires d'assister au congrès à un prix minimal. Nous encourageons les stagiaires intéressés à se prévaloir de cette opportunité à contacter les responsables locaux au sein de leur université sur la procédure à suivre. Pour les stagiaires provenant d'autres villes canadiennes, en partenariat avec les institutions locales, l'ACN attribuera de 25 à 40 bourses de voyage d'un montant de 500$ chacune pour aider à défrayer les frais de transport et de séjour. Les demandes doivent être soumises par courriel à jsbains(a)ucalgary.ca <mailto:jsbains@ucalgary.ca> et inclure : l'identification du candidat, le diplôme postulé, le nom du directeur de recherche, le programme dans lequel il(elle) est inscrit(e), l'université et/ou l'institut de recherche, le titre de la présentation, la liste des auteurs et le résumé complet. Pour être admissible à une bourse de voyage, le(la) stagiaire doit être premier(ère) auteur(e) et présentateur(trice) de l'affiche. Date limite de soumission des demandes : 12 avril 2011. This email was sent by Jaideep Bains, 4994 de Maisonneuve Ouest, Suite 103, Montreal, Quebec H3Z 3B9, using Express Email Marketing. You were added to this list as canderson(a)sbrc.ca on 11/25/2010. Express Email Marketing supports permission-based email marketing. You can change your preferences <http://app.expressemailmarketing.com/survey.aspx?id=96721&sid=135020939&cam…> or unsubscribe <http://app.expressemailmarketing.com/unsubscribe.aspx?id=96721&sid=13502093…> from this mailing list at any time. <http://app.expressemailmarketing.com/get.imgx?Opened=true&cid=731157&sid=13…>

1 0

WCSN Brain Awareness Week: Dr. Jack Antel - Public & Research Lectures
by Winnipeg Chapter Society for Neuroscience 16 Mar '11

16 Mar '11

REMINDER... The Winnipeg Chapter Society for Neuroscience together with the St. Boniface Hospital Research <http://www.sbrc.ca/> to host national speaker and clinical neurologist Dr. Jack Antel Public & Research Lectures by: Dr. Jack Antel Dr. Jack Antel, MD Neurologist - Clinical Research Unit Montreal Neurological Institute & Hospital ***Tonight.....Wednesday, March 16th, 2011 Public Lecture: "Progress in Multiple Sclerosis Research: Preventing the Damage and Promoting Repair" 7:00 - 8:00 PM Samuel Cohen Auditorium St. Boniface Hospital Research Centre 351 Tache Avenue Lecture Overview: The most common clinical features of multiple sclerosis in its initial disease course are recurrent episodes of neurologic dysfunction, termed "relapses," caused by inflamed lesions within the central nervous system. These lesions destroy critical membranes required for the central nervous system to function properly. Dr. Antel will discuss potential treatments for MS, including clinical therapies aimed at reducing inflammation and eliminating lesions. Current research is aimed at finding ways to not only stop membrane destruction, but to aid in the repair process. Coffee Reception 8:00 - 8:30 PM Atrium - Main Level St. Boniface Hospital Research Centre 351 Tache Avenue ------------------------- Tomorrow.....Thursday, March 17th, 2011 Research Lecture: "Mechanisms of tissue injury and repair in Multiple Sclerosis." 1:00 - 2:00 PM Theatre B - Basic Medical Sciences Bldg. University of Manitoba Coffee Reception 2:00 - 3:00 PM J.A. Hildes Concourse - Basic Medical Sciences Bldg. University of Manitoba Kelly Jorundson Winnipeg Chapter Society for Neuroscience R4046 - 351 Taché Avenue Winnipeg, MB R2H 2A6 CANADA Tel: 204.235.3939 7Fax: 204.237.4092 Email: kjorund(a)sbrc.ca <mailto:kjorund@sbrc.ca> Website: www.sfn-manitoba.ca

1 0